Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Not Recruiting

Trial ID: NCT01688414


This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer

Official Title

Utility of Fluorescence and Photoacoustic Imaging Intraoperatively to Assist With Robotic Assisted Minimally Invasive Surgery

Stanford Investigator(s)

Benjamin I. Chung
Benjamin I. Chung

Associate Professor of Urology

James D. Brooks
James D. Brooks

Keith and Jan Hurlbut Professor

Harcharan Gill
Harcharan Gill

Kathryn Simmons Stamey Professor, Emeritus

Nishita Kothary, MD
Nishita Kothary, MD

Professor of Radiology (Interventional Radiology)


Inclusion Criteria:

   - Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or
   kidney cancer based on previous biopsies or procedures OR a strong concern for a
   kidney malignancy based on computed tomography (CT) or magnetic resonance imaging
   (MRI) imaging

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Patients with a surgical history or anatomic variant that would preclude robot
   assisted laparoscopic approaches to their surgery (i.e. history of ventral hernia
   repair with mesh)

   - Patients with medical co-morbidities who cannot tolerate laparoscopic surgery
   secondary to intra-abdominal carbon dioxide insufflation

   - Patients with documented allergy or adverse drug reaction to indocyanine green or
   baseline serum creatinine greater than 1.5 mg/dL


procedure: photoacoustic imaging

procedure: fluorescence imaging

procedure: robot-assisted laparoscopic surgery

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Mark Gonzalgo

New Trial Alerts

Receive email alerts when trials open to patients.